Regina Au has 25+ years in the pharma/biotech, medical device and diagnostic industry with companies such as Merck & Co., Genzyme, NMT Medical, and Radi Medical (St. Jude Medical) in New Product Planning, Commercial, Marketing and Sales.
As a consultant, she helps companies maximize the benefits of their technology by conducting the business due diligence early in product development and to de-risk the product development process. This ensure that it is the right product for the right market in meeting a critical unmet need and that the market opportunity meets their business goals of the company. She will translate these unmet needs into a target product profile (TPP) or commercial profile. Ms. Au then develops marketing strategies to ensure product adoption and market access.
Ms. Au has written and published numerous articles on market and technology trends in the Journal of Pharmaceutics; the International Journal of Clinical Pharmacology and Pharmacotherapy; Advances in Biology, Biotechnology and Genetics; and Applied and Translational Genomics. Regina is on the Advisory Board for Regis College Masters of Regulatory and Clinical Research Management Program, a member of the Editorial Advisory Board for the International Journal of Clinical Pharmacology and Pharmacotherapy, Industry Advisor for the European Biopharmaceutical Review Journal, and an Advisor for the Massachusetts Technology Transfer Center Meetings for entrepreneurs.